Key result
Intermediate-high echocardiographic probability for pulmonary hypertension in pregnant women with elevated RVSP was associated with more MACE compared to low probability (40% vs 9%, P=0.01).
Why the study?
The use of echocardiography to evaluate the probability of pulmonary hypertension in pregnant women had not been reported or correlated with maternal outcomes.
Does intermediate-high echocardiographic probability of pulmonary hypertension predict major adverse cardiac events in pregnant women with elevated right ventricular systolic pressure compared to low probability?
Cohort (n=77)
Does intermediate-high echocardiographic probability of pulmonary hypertension predict major adverse cardiac events in pregnant women with elevated right ventricular systolic pressure compared to low probability?
Echocardiographic probability criteria for pulmonary hypertension can effectively risk-stratify pregnant women with elevated RVSP for major adverse cardiac events.
Answers are grounded in this paper and cite their sources.
May support echocardiographic risk stratification for MACE in pregnant women with elevated RVSP; leaves open prospective validation before practice change.
INTRODUCTION: The use of echocardiography to evaluate the probability for pulmonary hypertension (PH) in pregnant women has not been reported or correlated with outcomes. We hypothesized that in women with elevated right ventricular systolic pressure (RVSP) on echocardiography first identified during pregnancy, those with low probability for PH would have fewer major adverse cardiac events (MACE). METHODS: We performed a retrospective cohort study of pregnant women with RVSP >35 mm Hg on echocardiogram first identified during pregnancy. Women were classified as intermediate-high probability for PH (HP) or low probability for PH (LP) based on simplified European Society of Cardiology echocardiographic criteria. Maternal cardiac, obstetric, and fetal outcomes were assessed. RESULTS: A total of 77 women met inclusion criteria (mean age 30 ± 5 years), with 45 (58%) classified as HP and 32 (42%) as LP. There were 21 (27%) women who experienced MACE, more commonly in the HP cohort (HP 18 (40%) women vs. LP 3 (9%) women, P = .01). The echocardiographic criteria for intermediate-high probability of PH identified women at risk for MACE with 85% sensitivity and 52% specificity. The negative predictive value for MACE in women meeting low echocardiographic probability for PH criteria was 91%. CONCLUSIONS: In women with elevated RVSP on echocardiography first identified during pregnancy, those with low echocardiographic PH probability are at significantly lower risk for MACE during pregnancy, though the risk is not eliminated. This may be useful to risk stratify pregnant women with suspected PH, guiding tertiary care referral and invasive catheterization.
No takes yet. Share an insight, caveat, or question.
Marshall et al. (2021) conducted a cohort in elevated right ventricular systolic pressure in pregnancy (n=77). Intermediate-high probability for pulmonary hypertension vs. Low probability for pulmonary hypertension was evaluated on major adverse cardiac events (MACE) (p=0.01). Intermediate-high echocardiographic probability for pulmonary hypertension in pregnant women with elevated RVSP was associated with more MACE compared to low probability (40% vs 9%, P=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: